Blue Star Limited has announced the successful completion of the sale and transfer of its MedTech business, operated by its subsidiary Blue Star Engineering & Electronics Limited (Blue Star E&E), to Cyrix Healthcare Private Limited. The transaction, effective September 1, 2026, was completed on a slump sale basis. Consideration for the sale is payable in tranches, with the final payment due by March 31, 2027.
MedTech Business Transfer Finalized
Blue Star Limited has confirmed the completion of the sale and transfer of its MedTech business, which was formerly part of its wholly-owned subsidiary, Blue Star Engineering & Electronics Limited (Blue Star E&E). The business has been successfully transferred to Cyrix Healthcare Private Limited.
Transaction Details and Timeline
This transaction was executed as a slump sale, covering Blue Star E&E’s MedTech division, which provides high-end medical diagnostic equipment and services. The transfer of the business was made effective from September 1, 2026. The acknowledgment of this transfer by Cyrix was received on September 1, 2026.
The total consideration for this sale is structured in tranches, subject to potential adjustments. The final payment is scheduled to be made by March 31, 2027.
Blue Star Limited had previously intimated about the execution of the Business Transfer Agreement (BTA) for this sale on August 14, 2026.
Source: BSE
